Filippo Acconcia

Filippo Acconcia

Sep 24, 2017

Group 6 Copy 219
1
Please wait...

About This Project

70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

Blast off!

Browse Other Projects on Experiment

Related Projects

Antibiotics and Affect: Avenues for Addiction Management

Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

Community-based Leishmaniasis research in Sri Lanka

Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

Can anle138b delay the onset of genetic prion disease?

Prions - infectious proteins - cause fatal, untreatable neurodegenerative diseases. A promising new compound...

Campaign Ended